Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Edgewise Therapeutics Inc (NQ: EWTX ) 18.42 -0.43 (-2.28%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Edgewise Therapeutics Inc < Previous 1 2 3 4 5 6 Next > 6 Blue-Chip Stocks to Sell Now July 18, 2022 This article is about 6 blue-chip stocks to sell now. They are severely overvalued or are likely to move down soon with a recession. Via InvestorPlace Edgewise Therapeutics Initiates Mid-Stage Muscular Dystrophies Study July 12, 2022 Edgewise Therapeutics (NASDAQ: EWTX) announced the initiation of the CANYON Phase 2 clinical trial evaluating EDG-5506 in individuals with Becker Muscular Dystrophy (BMD). Via Benzinga Edgewise Therapeutics Now Enrolling CANYON Phase 2 Clinical Trial of EDG-5506 in Individuals with Becker Muscular Dystrophy (BMD) July 12, 2022 From Edgewise Therapeutics Via Business Wire RBC Capital Says This Dystrophy Stock 'Is Worth A Look' June 22, 2022 Via Benzinga The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial June 21, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Edgewise's Dystrophy Candidate Lowers Muscle Damage Biomarkers June 21, 2022 Via Benzinga Recap: Edgewise Therapeutics Q1 Earnings May 11, 2022 Edgewise Therapeutics (NASDAQ:EWTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Edgewise Therapeutics Announces Positive 2-Month Interim Results from the ARCH Open Label Study of EDG-5506 in Adults with Becker Muscular Dystrophy (BMD) June 20, 2022 From Edgewise Therapeutics Via Business Wire New 2-Month Interim Data from the ARCH Open Label Study of EDG-5506 in Individuals with Becker Muscular Dystrophy (BMD) to be Presented at the Upcoming New Directions in Biology and Disease of Skeletal Muscle Conference June 16, 2022 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics to Present at Upcoming Investor Conferences May 31, 2022 From Edgewise Therapeutics Via Business Wire Stocks That Hit 52-Week Lows On Friday March 25, 2022 On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga Analyst Ratings for Edgewise Therapeutics May 12, 2022 Over the past 3 months, 4 analysts have published their opinion on Edgewise Therapeutics (NASDAQ:EWTX) stock. These analysts are typically employed by large Wall Street banks and tasked with... Via Benzinga Edgewise Therapeutics Reports First Quarter 2022 Financial Results May 11, 2022 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics to Present at Upcoming Investor Conferences May 03, 2022 From Edgewise Therapeutics Via Business Wire Edgewise-Funded Natural History Trial of Becker Muscular Dystrophy (BMD) Now Enrolling April 14, 2022 From Edgewise Therapeutics Via Business Wire Stocks That Hit 52-Week Lows On Thursday March 24, 2022 On Thursday, 112 stocks made new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Stanley Black & Decker (NYSE:SWK) was the largest firm by market... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday March 23, 2022 On Wednesday, 63 companies set new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was... Via Benzinga The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study March 16, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings March 13, 2022 Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments... Via Benzinga Edgewise Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results February 24, 2022 From Edgewise Therapeutics Via Business Wire Edgewise Therapeutics to Participate at SVB Leerink 11th Annual Global Healthcare Conference on February 16 February 02, 2022 From Edgewise Therapeutics Via Business Wire 52 Biggest Movers From Friday January 31, 2022 Gainers Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share. Imperial Petroleum Inc. (NASDAQ:... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session January 28, 2022 Gainers Provention Bio (NASDAQ:PRVB) stoc... Via Benzinga Stocks Move Higher Midday, Still Pacing for Weekly Losses January 28, 2022 Stocks are continuing their rollercoaster pattern midday, as Wall Street attempts to lift itself out of the worst selloff since March 2020. Via Talk Markets 33 Stocks Moving In Friday's Mid-Day Session January 28, 2022 Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 126% to $2.6219. Imperial Petroleum, last month, posted Q3 revenue of $4.1 million. Yoshitsu Co., Ltd (NASDAQ: TKLF... Via Benzinga 50 Biggest Movers From Yesterday January 06, 2022 Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead... Via Benzinga Mid-Afternoon Market Update: Nasdaq Down 300 Points; Annexon Shares Plunge January 05, 2022 Toward the end of trading Wednesday, the Dow traded up 0.24% to 36,711.36 while the NASDAQ fell 1.93% to 15,321.38. The S&P also fell, dropping 0.80% to 4,755.18. The U.S. has... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 05, 2022 Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is... Via Benzinga 34 Stocks Moving In Wednesday's Mid-Day Session January 05, 2022 Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 49.7% to $15.45 after the company announced it acquired exclusive rights to novel mRNA biomarkers. Data Storage... Via Benzinga Edgewise Therapeutics Shares Jump After Positive Data On Becker Muscular Dystrophy Study January 05, 2022 Edgewise Therapeutics Inc (NASDAQ: EWTX) posted positive topline results from Phase 1b trial of EDG-5506, designed to protect injury-susceptible fast skeletal... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.